Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 6Breast Neoplasms 5Ovarian Neoplasms 4Endometrial Neoplasms 4Pancreatic Neoplasms 3Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Uterine Neoplasms 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lung Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Glioma 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 4pembrolizumab 3selpercatinib 2pralsetinib 2Pemetrexed 2Paclitaxel 2Fulvestrant 2Carboplatin 2trametinib 1ribociclib 1repotrectinib 1patritumab 1palbociclib 1golotimod 1exemestane 1dabrafenib 1cobimetinib 1alectinib 1abemaciclib 1Vemurafenib 1Taxes 1Tamoxifen 1STX-478 1Radiotherapy, Intensity-Modulated 1Nimorazole 1Metformin 1Letrozole 1Imlunestrant 1Gemcitabine 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × palbociclib × Head & Neck × Clear all
NCT05768139 2026-06-04

PIKALO-1

Eli Lilly and Company

Phase 1/2 Recruiting
880 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡